Future Oncology Journal Issues Research Articles in Vol. 17, No. 5
February 09, 2021
February 09, 2021
LONDON, England, Feb. 9 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 17, No. 5 edition:
Clinical Trial Protocol:
* First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
Short Communication:
* Real-world treatment patterns, healthcare use and costs in triple-class expose . . .
Clinical Trial Protocol:
* First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
Short Communication:
* Real-world treatment patterns, healthcare use and costs in triple-class expose . . .